Not applicableStudy completedNCT01073462
What this trial is testing
Study to Evaluate the Effect of Intravenous (IV) Paricalcitol (Zemplar) on Cardiac Morbidity in Patients With Chronic Kidney Disease (CKD) Stage 5 Over 2 Years
Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease Stage VCardiac Morbidity
AbbVie (prior sponsor, Abbott) 67